Low-Dose Oral Naltrexone for Darier Disease
Low-Dose Oral Naltrexone for Darier Disease Cutis. 2025 May;115(5):E1-E2 | doi:10.12788/cutis.1220 May 16, 2025 Authors: Vanessa Castro, MD;Oscar Bautista, MD;Gabriela Salgado, MD;Estefanía Fernández, MD;Tullia Cuzzi, MD, PhD;Luna Azulay-Abulafia, MD, PhD https://www.mdedge.com/cutis/article/272539/mixed-topics/low-dose-oral-naltrexone-darier-disease PRACTICE POINTS Consider low-dose naltrexone as a potential treatment option for patients with Darier disease, as it regulates opioid receptors and has shown benefits […]
Segmental Darier’s disease: A case report (Abstract)
Segmental Darier’s disease: A case report SAGE Open Med Case Rep 03 April 2023 https://pubmed.ncbi.nlm.nih.gov/37032996/ Segmental Darier’s disease is an uncommon subtype of Darier’s genodermatosis, resulting from a mutation in the ATPase type 2 during early embryogenesis. It typically presents as a persistent, pruritic papular eruption following the lines of Blaschko. Histopathology of Darier’s disease […]
Combination of Naltrexone and Isotretinoin for the Treatment of Darier Disease (Abstract)
Combination of Naltrexone and Isotretinoin for the Treatment of Darier Disease Cureus 03 January 2023 https://www.cureus.com/articles/130848-combination-of-naltrexone-and-isotretinoin-for-the-treatment-of-darier-disease Darier disease (DD) is an autosomal-dominant genodermatosis in which mutations in the ATP2A2 gene result in impaired intercellular adhesion and epidermal blistering. Treatment options usually rely on systemic retinoids, but a refractory disease is still a therapeutical challenge. Given […]
The LDN Book 3 (LDN; low dose naltrexone)
The LDN 3: To Purchase with discounts before 1st September 2022 Go to ldnresearchtrust.org/ldn-book-3 for full details
Dosing of Low Dose Naltrexone (LDN)
Sleep Issues and Low Dose Naltrexone (LDN)
The Immune System and Low Dose Naltrexone (LDN)
LDN Webinar 18 May 2022 (LDN; low dose naltrexone)
LDN Webinar 18 May 2022 (LDN; low dose naltrexone) LDN Questions Answered Live by Pharmacist Dr Masoud Rashidi – LDN Specialist Dr Sato-Re Dr Mathewson Sponsored by Innovative Compounding Pharmacy icpfolsom.com